Lv5
1020 积分 2024-10-18 加入
Drugging KRAS: current perspectives and state-of-art review
8小时前
待确认
Direct K-Ras Inhibitors to Treat Cancers: Progress, New Insights, and Approaches to Treat Resistance
11小时前
待确认
Precision oncology provides opportunities for targeting KRAS-inhibitor resistance
11小时前
待确认
KRAS mutation: from undruggable to druggable in cancer
15小时前
已完结
Targeting KRASG12C Mutation: Development of Effective Strategies to Overcome Drug Resistance and Limited Efficacy
29天前
已完结
Precision oncology provides opportunities for targeting KRAS-inhibitor resistance
29天前
已完结
Mechanistic Foundations of KRAS‐Driven Tumor Ecosystems: Integrating Crosstalk among Immune, Metabolic, Microbial, and Stromal Microenvironment
29天前
已完结
Direct K-Ras Inhibitors to Treat Cancers: Progress, New Insights, and Approaches to Treat Resistance
29天前
已完结
Activity and resistance to KRASG12C inhibitors in non-small cell lung cancer and colorectal cancer
29天前
已完结
Structural Basis for Phosphodependent Substrate Selection and Orientation by the SCFCdc4 Ubiquitin Ligase
1个月前
已完结
皖公网安备34019202002308
